Search - tctmd.com

Displaying 141 - 160 of 361

Sort: Relevancy | Date

Presentation TCT 2021

A Novel Sirolimus-Eluting Iron-Based Bioresorbable Scaffold Implantation in Single De Novo Coronary Lesions: Two-Year Clinical and Imaging Outcomes from the First in Man Study (IBS-FIM)

Presenter: Runlin Gao

November 05, 2021

Presentation TCT 2021

The MAGICAL trial – Insights from the upcoming US IDE DCB study

Presenter: Martin Leon

November 05, 2021

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

Presentation TCT 2021

FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report: Final 5 Year Clinical Outcomes

Presenter: Matthias Lutz

November 04, 2021

News Conference News TCT 2021

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

L.A. McKeown

October 25, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

The OPTIMIZE IDE: TrialProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presentation TCT 2020

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presenter: Dean J. Kereiakes

October 17, 2020

Presentation TCT 2020

Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients

Presenter: Michel Bosiers

October 15, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

Presentation TCT 2020

TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation

Presenter: Matthias Lutz

October 14, 2020

Presentation TCT 2020

TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischaemia: The CREDENCE BtK-1 Study

Presenter: Vijay Thakore

October 14, 2020

Presentation TCT 2020

TCT 374: Adventitial Delivery of Nano-encapsulated Sirolimus (Nanolimus) to Reduce Restenosis in Injured Porcine Femoral Arteries

Presenter: Hui Ying Ang

October 14, 2020

Presentation TCT 2020

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

Presenter: Prakash Ajmera

October 14, 2020

Presentation TCT 2020

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

Presenter: Martin Hudec

October 14, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation TCT 2020

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Presenter: Alexandre Abizaid

October 14, 2020

Presentation TCT 2020

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

Presenter: A D S P K Athukorala

October 14, 2020

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Advertisement

A Novel Sirolimus-Eluting Iron-Based Bioresorbable Scaffold Implantation in Single De Novo Coronary Lesions: Two-Year Clinical and Imaging Outcomes from the First in Man Study (IBS-FIM)

The MAGICAL trial – Insights from the upcoming US IDE DCB study

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report: Final 5 Year Clinical Outcomes

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

Good Long-term Results With FANTOM BVS, but More Data Needed

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation

TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischaemia: The CREDENCE BtK-1 Study

TCT 374: Adventitial Delivery of Nano-encapsulated Sirolimus (Nanolimus) to Reduce Restenosis in Injured Porcine Femoral Arteries

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content